Surrogate Outcome Measures of In Vitro Osteoclast Resorption of β Tricalcium Phosphate
Source abstract
Abstract
Introduction of porosity to calcium phosphate scaffolds for bone repair has created a new challenge when measuring bioresorption in vitro, rendering traditional outcome measures redundant. The aim of this study is to identify a surrogate endpoint for use with 3D scaffolds. Murine RAW 264.7 cells are cultured on dense discs of β‐tricalcium phosphate in conditions to stimulate osteoclast (OC) formation. Multinucleated OCs are visible from day 6 with increases at days 8 and 10. Resorption pits are first observed at day 6 with much larger pits visible at days 8, 10, and 12. The concentration of calcium ions in the presence of cells is significantly higher than cell‐free cultures at days 3 and 9. Using linear regression analysis, Ca ion release could account for 35.9% of any subsequent change in resorption area. The results suggest that Ca ion release is suitable to measure resorption of a beta‐tricalcium phosphate ceramic substrate in vitro. This model could replace the more accepted resorption pit assay in circumstances where quantification of pits is not possible, e.g., when characterizing 3D tissue engineered bone scaffolds.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Bone and Dental Protein Studies · Bone health and osteoporosis research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
School of Nursing and Midwifery Medical Biology Centre 97, Lisburn Road Belfast BT9 7BL UK
School of Mechanical and Aerospace Engineering Queen's University Belfast Ashby Building, Stranmillis Rd Belfast BT9 5AH UK
School of Biological Sciences Queens University Belfast MBC, 97 Lisburn Rd Belfast BT9 7BL UK
LMCPA Université Valencienne Maubeuge 59313 France
Skeletal Substitutes Group RMS Foundation Bischmattstr. 12 CH‐2544 Bettlach Switzerland
Funding
Department for Employment and Learning, Northern Ireland
References (60)
Show source-provided references
1. 10.1016/j.injury.2005.07.02910.1016/j.injury.2005.07.029 ↗
2. 10.1016/S1369-7021(10)70014-610.1016/S1369-7021(10)70014-6 ↗
3. Summers B. N. · J. Bone Joint Surg‐Br. Vol. · 1989 · 71 · 67710.1302/0301-620X.71B4.2768321 ↗
4. 10.1097/00003086-199605000-0000810.1097/00003086-199605000-00008 ↗
5. 10.1098/rsta.2004.146610.1098/rsta.2004.1466 ↗
6. 10.1016/0142-9612(95)91092-D10.1016/0142-9612(95)91092-D ↗
7. 10.1177/088532820606512510.1177/0885328206065125 ↗
8. 10.1016/S0142-9612(97)00180-410.1016/S0142-9612(97)00180-4 ↗
9. 10.1016/j.biomaterials.2007.01.04610.1016/j.biomaterials.2007.01.046 ↗
10. 10.1016/j.biomaterials.2005.02.00210.1016/j.biomaterials.2005.02.002 ↗
11. 10.1016/S0142-9612(00)00290-810.1016/S0142-9612(00)00290-8 ↗
12. 10.1002/jbm.a.1043210.1002/jbm.a.10432 ↗
13. 10.1016/j.knee.2008.02.00510.1016/j.knee.2008.02.005 ↗
14. 10.1002/jbm.b.3104110.1002/jbm.b.31041 ↗
15. 10.1016/j.biomaterials.2006.05.05110.1016/j.biomaterials.2006.05.051 ↗
16. 10.1038/sj.bdj.480531310.1038/sj.bdj.4805313 ↗
17. 10.1242/jcs.66.1.38310.1242/jcs.66.1.383 ↗
18. 10.1007/BF0256512310.1007/BF02565123 ↗
19. Arnett T. R. · 1998
20. 10.1002/jemt.2032610.1002/jemt.20326 ↗
21. 10.1002/jemt.2065410.1002/jemt.20654 ↗
22. 10.1016/j.actbio.2010.04.01510.1016/j.actbio.2010.04.015 ↗
23. 10.1016/j.msec.2006.08.00610.1016/j.msec.2006.08.006 ↗
24. 10.1016/j.actbio.2007.03.01410.1016/j.actbio.2007.03.014 ↗
25. 10.1016/j.biomaterials.2003.10.07910.1016/j.biomaterials.2003.10.079 ↗
26. 10.1093/clinchem/47.1.7410.1093/clinchem/47.1.74 ↗
27. 10.1002/jcb.2083510.1002/jcb.20835 ↗
28. 10.1007/BF0162345810.1007/BF01623458 ↗
29. 10.1016/j.bone.2003.04.00210.1016/j.bone.2003.04.002 ↗
30. 10.1016/S1389-0344(02)00023-010.1016/S1389-0344(02)00023-0 ↗
31. 10.1016/j.jeurceramsoc.2006.09.00510.1016/j.jeurceramsoc.2006.09.005 ↗
32. 10.1210/endo-119-1-11910.1210/endo-119-1-119 ↗
33. 10.1016/j.actbio.2015.07.04010.1016/j.actbio.2015.07.040 ↗
34. 10.1371/journal.pone.000210410.1371/journal.pone.0002104 ↗
35. 10.1002/jbmr.565009041510.1002/jbmr.5650090415 ↗
36. 10.1016/j.bcp.2004.08.03610.1016/j.bcp.2004.08.036 ↗
37. 10.1002/art.2744110.1002/art.27441 ↗
38. 10.1002/jcb.2155910.1002/jcb.21559 ↗
39. 10.1093/ortho/25.2.10110.1093/ortho/25.2.101 ↗
40. 10.1016/j.ejcb.2008.01.00110.1016/j.ejcb.2008.01.001 ↗
41. 10.1210/endo-120-2-60210.1210/endo-120-2-602 ↗
42. 10.1002/(SICI)1521-1878(199810)20:10<837::AID-BIES9>3.0.CO;2-D10.1002/(SICI)1521-1878(199810)20:10<837::AID-BIES9>3.0.CO;2-D ↗
43. 10.1074/jbc.272.30.1863610.1074/jbc.272.30.18636 ↗
44. 10.1016/0014-4827(88)90191-710.1016/0014-4827(88)90191-7 ↗
45. 10.1016/0109-5641(89)90133-410.1016/0109-5641(89)90133-4 ↗
46. 10.1177/0022034581060003070110.1177/00220345810600030701 ↗
47. Norling B. K. · 1986 · 1047
48. Heymann D. · Histol. Histopathol. · 2001 · 16 · 37
49. Heymann D. · Histol. Histopathol. · 1999 · 14 · 871
50. 10.1074/jbc.271.21.1251710.1074/jbc.271.21.12517 ↗
51. Delaisse J. M. · J. Cell Sci. · 1993 · 106 · 107110.1242/jcs.106.4.1071 ↗
52. 10.1074/jbc.272.35.2205310.1074/jbc.272.35.22053 ↗
53. 10.1359/jbmr.2003.18.4.59910.1359/jbmr.2003.18.4.599 ↗
54. 10.1039/c3ib40027a10.1039/c3ib40027a ↗
55. 10.1016/j.actbio.2008.09.01710.1016/j.actbio.2008.09.017 ↗
56. 10.1016/j.biomaterials.2010.01.12110.1016/j.biomaterials.2010.01.121 ↗
57. 10.1002/jbm.1002610.1002/jbm.10026 ↗
58. 10.1016/j.actbio.2012.10.01010.1016/j.actbio.2012.10.010 ↗
59. 10.1016/j.actbio.2010.08.00810.1016/j.actbio.2010.08.008 ↗
60. 10.1038/nmeth.208910.1038/nmeth.2089 ↗